{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:47:56Z","timestamp":1792165676165,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:00:00Z","timestamp":1784332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82525045"],"award-info":[{"award-number":["82525045"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20451"],"award-info":[{"award-number":["U23A20451"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573175"],"award-info":[{"award-number":["82573175"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372917"],"award-info":[{"award-number":["82372917"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003397","name":"Huazhong University of Science and Technology","doi-asserted-by":"publisher","award":["2023BR038"],"award-info":[{"award-number":["2023BR038"]}],"id":[{"id":"10.13039\/501100003397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2026AFB313"],"award-info":[{"award-number":["2026AFB313"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M781987"],"award-info":[{"award-number":["2025M781987"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08634-9","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T19:23:08Z","timestamp":1784402588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypoxia tumor-associated macrophages facilitate hepatocellular carcinoma metastasis via uPA-uPAR pathway"],"prefix":"10.1186","volume":"24","author":[{"given":"Yijun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyuan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zerui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6327-6034","authenticated-orcid":false,"given":"Limin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,18]]},"reference":[{"key":"8634_CR1","doi-asserted-by":"crossref","unstructured":"Le Couteur DG, Ngu MC, Hunt NJ, Brandon AE, Simpson SJ, Cogger VC. Liver, ageing and disease. Nat Rev Gastroenterol Hepatol 2025;680\u201395.","DOI":"10.1038\/s41575-025-01099-z"},{"key":"8634_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12943-025-02378-8","volume":"24","author":"X Su","year":"2025","unstructured":"Su X, Yan X, Zhang H. The tumor microenvironment in hepatocellular carcinoma: mechanistic insights and therapeutic potential of traditional Chinese medicine. Mol Cancer. 2025;24:173.","journal-title":"Mol Cancer"},{"key":"8634_CR3","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1158\/0008-5472.CAN-20-2990","volume":"81","author":"NR Anderson","year":"2021","unstructured":"Anderson NR, Minutolo NG, Gill S, Klichinsky M. Macrophage-Based Approaches for Cancer Immunotherapy. Cancer Res. 2021;81:1201\u20138.","journal-title":"Cancer Res"},{"key":"8634_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41392-025-02325-5","volume":"10","author":"J Xu","year":"2025","unstructured":"Xu J, Ding L, Mei J, Hu Y, Kong X, Dai S, et al. Dual roles and therapeutic targeting of tumor-associated macrophages in tumor microenvironments. Signal Transduct Target Ther. 2025;10:268.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"8634_CR5","doi-asserted-by":"publisher","first-page":"892","DOI":"10.7150\/thno.87962","volume":"14","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Tsui YM, Zhang VX, Lu AJ, Lee JM, Lee E, Cheung GC, Li PM, Cheung ET, Chia NH, Lo IL, Chan AC, Cheung TT, Ng IO, Ho DW. Reciprocal interactions between malignant cells and macrophages enhance cancer stemness and M2 polarization in HBV-associated hepatocellular carcinoma. Theranostics. 2024;14(2):892\u2013910.","journal-title":"Theranostics"},{"key":"8634_CR6","doi-asserted-by":"publisher","first-page":"102463","DOI":"10.1016\/j.redox.2022.102463","volume":"56","author":"X Hao","year":"2022","unstructured":"Hao X, Zheng Z, Liu H, Zhang Y, Kang J, Kong X, Rong D, Sun G, Sun G, Liu L, Yu H, Tang W, Wang X. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. Redox Biol. 2022;56:102463.","journal-title":"Redox Biol"},{"issue":"1","key":"8634_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s10555-025-10251-9","volume":"44","author":"TH Chen","year":"2025","unstructured":"Chen TH, Lin SH, Lee MY, Wang HC, Tsai KF, Chou CK. Mitochondrial alterations and signatures in hepatocellular carcinoma. Cancer Metastasis Rev. 2025;44(1):34.","journal-title":"Cancer Metastasis Rev"},{"issue":"7","key":"8634_CR8","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.3390\/cells10071715","volume":"10","author":"MH Bao","year":"2021","unstructured":"Bao MH, Wong CC, Hypoxia. Metabolic Reprogramming, and Drug Resistance in Liver Cancer. Cells. 2021;10(7):1715.","journal-title":"Cells"},{"issue":"1","key":"8634_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12943-024-02064-1","volume":"23","author":"X Chu","year":"2024","unstructured":"Chu X, Tian Y, Lv C. Decoding the spatiotemporal heterogeneity of tumor-associated macrophages. Mol Cancer. 2024;23(1):150.","journal-title":"Mol Cancer"},{"issue":"1","key":"8634_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13045-024-01634-6","volume":"18","author":"A Glaviano","year":"2025","unstructured":"Glaviano A, Lau HS, Carter LM, Lee EHC, Lam HY, Okina E, Tan DJJ, Tan W, Ang HL, Carbone D, Yee MY, Shanmugam MK, Huang XZ, Sethi G, Tan TZ, Lim LHK, Huang RY, Ungefroren H, Giovannetti E, Tang DG, Bruno TC, Luo P, Andersen MH, Qian BZ, Ishihara J, Radisky DC, Elias S, Yadav S, Kim M, Robert C, Diana P, Schalper KA, Shi T, Merghoub T, Krebs S, Kusumbe AP, Davids MS, Brown JR, Kumar AP. Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition. J Hematol Oncol. 2025;18(1):6.","journal-title":"J Hematol Oncol"},{"issue":"38","key":"8634_CR11","doi-asserted-by":"publisher","first-page":"eadq5226","DOI":"10.1126\/sciadv.adq5226","volume":"10","author":"C de la Calle-Fabregat","year":"2024","unstructured":"de la Calle-Fabregat C, Calafell-Segura J, Gardet M, Dunsmore G, Mulder K, Ciudad L, Silvin A, Moreno-C\u00e0ceres J, Corb\u00ed \u00c1L, Mu\u00f1oz-Pinedo C, Michels J, Gouy S, Dutertre CA, Rodr\u00edguez-Ubreva J, Ginhoux F, Ballestar E. NF-\u03baB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment. Sci Adv. 2024;10(38):eadq5226.","journal-title":"Sci Adv"},{"issue":"5","key":"8634_CR12","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ccell.2024.03.013","volume":"42","author":"W Wang","year":"2024","unstructured":"Wang W, Li T, Cheng Y, Li F, Qi S, Mao M, Wu J, Liu Q, Zhang X, Li X, Zhang L, Qi H, Yang L, Yang K, He Z, Ding S, Qin Z, Yang Y, Yang X, Luo C, Guo Y, Wang C, Liu X, Zhou L, Liu Y, Kong W, Miao J, Ye S, Luo M, An L, Wang L, Che L, Niu Q, Ma Q, Zhang X, Zhang Z, Hu R, Feng H, Ping YF, Bian XW, Shi Y. Identification of hypoxic macrophages in glioblastoma with therapeutic potential for vasculature normalization. Cancer Cell. 2024;42(5):815\u2013e83212.","journal-title":"Cancer Cell"},{"key":"8634_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.cancergen.2025.04.008","volume":"294\u2013295","author":"H Yin","year":"2025","unstructured":"Yin H, Zhang Z, Zhang Q, You Y, Zhang Z, Han Y, Zhang Q, You B. PLAU serves as a prognostic biomarker correlated with perineural invasion in HNSCC. Cancer Genet. 2025;294\u2013295:145\u201355. https:\/\/doi.org\/10.1016\/j.cancergen.2025.04.008.","journal-title":"Cancer Genet"},{"issue":"1","key":"8634_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41420-021-00410-6","volume":"7","author":"L Fang","year":"2021","unstructured":"Fang L, Che Y, Zhang C, Huang J, Lei Y, Lu Z, Sun N, He J. PLAU directs conversion of fibroblasts to inflammatory cancer-associated fibroblasts, promoting esophageal squamous cell carcinoma progression via uPAR\/Akt\/NF-\u03baB\/IL8 pathway. Cell Death Discov. 2021;7(1):32. https:\/\/doi.org\/10.1038\/s41420-021-00410-6. PMID: 33574243; PMCID: PMC7878926.","journal-title":"Cell Death Discov"},{"issue":"1","key":"8634_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12935-025-03867-y","volume":"25","author":"J Zou","year":"2025","unstructured":"Zou J, Zhang J, Li Y, Yuan B, Wang Y, Qi Y, Wang Q, Qin W, Yuan X, Xu B. Stromal PLAU mediates tumor progression and informs a novel therapeutic target in triple-negative breast cancer. Cancer Cell Int. 2025;25(1):259.","journal-title":"Cancer Cell Int"},{"key":"8634_CR16","doi-asserted-by":"publisher","first-page":"651882","DOI":"10.3389\/fgene.2021.651882","volume":"12","author":"G Chen","year":"2021","unstructured":"Chen G, Sun J, Xie M, Yu S, Tang Q, Chen L. PLAU Promotes Cell Proliferation and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma. Front Genet. 2021;12:651882.","journal-title":"Front Genet"},{"issue":"1","key":"8634_CR17","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1186\/s12885-019-6397-3","volume":"19","author":"MC Tsai","year":"2019","unstructured":"Tsai MC, Yen YH, Chang KC, Hung CH, Chen CH, Lin MT, Hu TH. Elevated levels of serum urokinase plasminogen activator predict poor prognosis in hepatocellular carcinoma after resection. BMC Cancer. 2019;19(1):1169.","journal-title":"BMC Cancer"},{"issue":"11","key":"8634_CR18","doi-asserted-by":"publisher","first-page":"4560","DOI":"10.7150\/ijbs.69933","volume":"18","author":"T Zhang","year":"2022","unstructured":"Zhang T, Wang B, Su F, Gu B, Xiang L, Gao L, Zheng P, Li XM, Chen H. TCF7L2 promotes anoikis resistance and metastasis of gastric cancer by transcriptionally activating PLAUR. Int J Biol Sci. 2022;18(11):4560\u201377.","journal-title":"Int J Biol Sci"},{"issue":"7","key":"8634_CR19","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1158\/0008-5472.CAN-12-3526","volume":"73","author":"AM LeBeau","year":"2013","unstructured":"LeBeau AM, Duriseti S, Murphy ST, Pepin F, Hann B, Gray JW, VanBrocklin HF, Craik CS. Targeting uPAR with antagonistic recombinant human antibodies in aggressive breast cancer. Cancer Res. 2013;73(7):2070\u201381.","journal-title":"Cancer Res"},{"key":"8634_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s40537-023-00844-y","volume":"10","author":"Z Liu","year":"2023","unstructured":"Liu Z, Liu L, Weng S, Xu H, Xing Z, Ren Y, et al. BEST: a web application for comprehensive biomarker exploration on large-scale data in solid tumors. J Big Data. 2023;10:165.","journal-title":"J Big Data"},{"issue":"6","key":"8634_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s12032-023-02018-5","volume":"40","author":"A Fauziya, Gupta","year":"2023","unstructured":"Fauziya, Gupta A, Nadaf A, Ahmad S, Hasan N, Imran M, Sahebkar A, Jain GK, Kesharwani P, Ahmad FJ. Dasatinib: a potential tyrosine kinase inhibitor to fight against multiple cancer malignancies. Med Oncol. 2023;40(6):173.","journal-title":"Med Oncol"},{"issue":"6","key":"8634_CR22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.ctrv.2010.02.015","volume":"36","author":"J Araujo","year":"2010","unstructured":"Araujo J, Logothetis C. Dasatinib: a potent SRC inhibitor in clinical development for the treatment of solid tumors. Cancer Treat Rev. 2010;36(6):492\u2013500.","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"8634_CR23","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.jhep.2024.09.029","volume":"82","author":"X Yang","year":"2025","unstructured":"Yang X, Deng B, Zhao W, Guo Y, Wan Y, Wu Z, Su S, Gu J, Hu X, Feng W, Hu C, Li J, Xu Y, Huang X, Lin Y. FABP5 + lipid-loaded macrophages process tumour-derived unsaturated fatty acid signal to suppress T-cell antitumour immunity. J Hepatol. 2025;82(4):676\u201389.","journal-title":"J Hepatol"},{"issue":"11","key":"8634_CR24","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1002\/cac2.12345","volume":"42","author":"K Cheng","year":"2022","unstructured":"Cheng K, Cai N, Zhu J, Yang X, Liang H, Zhang W. Tumor-associated macrophages in liver cancer: From mechanisms to therapy. Cancer Commun (Lond). 2022;42(11):1112\u201340.","journal-title":"Cancer Commun (Lond)"},{"issue":"7","key":"8634_CR25","doi-asserted-by":"publisher","first-page":"487","DOI":"10.7150\/thno.4218","volume":"3","author":"H Noh","year":"2013","unstructured":"Noh H, Hong S, Huang S. Role of urokinase receptor in tumor progression and development. Theranostics. 2013;3(7):487\u201395.","journal-title":"Theranostics"},{"issue":"10","key":"8634_CR26","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1161\/ATVBAHA.124.321603","volume":"45","author":"Y Hisada","year":"2025","unstructured":"Hisada Y, Mackman N. Profibrinolytic Factors and Cancer Progression, Metastasis, and Survival. Arterioscler Thromb Vasc Biol. 2025;45(10):1732\u201341.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"8634_CR27","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.ctrv.2007.06.003","volume":"33","author":"Y Li","year":"2007","unstructured":"Li Y, Cozzi PJ. Targeting uPA\/uPAR in prostate cancer. Cancer Treat Rev. 2007;33(6):521\u20137.","journal-title":"Cancer Treat Rev"},{"issue":"1","key":"8634_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13045-025-01739-6","volume":"18","author":"S Dai","year":"2025","unstructured":"Dai S, Chen Y, Cai W, Dong S, Zhao J, Chen L, Cheng CS. Combination immunotherapy in hepatocellular carcinoma: synergies among immune checkpoints, TKIs, and chemotherapy. J Hematol Oncol. 2025;18(1):85.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"8634_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","volume":"10","author":"J Zheng","year":"2025","unstructured":"Zheng J, Wang S, Xia L, Sun Z, Chan KM, Bernards R, Qin W, Chen J, Xia Q, Jin H. Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduct Target Ther. 2025;10(1):35.","journal-title":"Signal Transduct Target Ther"},{"issue":"15","key":"8634_CR30","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1200\/JCO.23.02745","volume":"42","author":"JD Gordan","year":"2024","unstructured":"Gordan JD, Kennedy EB, Abou-Alfa GK, Beal E, Finn RS, Gade TP, Goff L, Gupta S, Guy J, Hoang HT, Iyer R, Jaiyesimi I, Jhawer M, Karippot A, Kaseb AO, Kelley RK, Kortmansky J, Leaf A, Remak WM, Sohal DPS, Taddei TH, Wilson Woods A, Yarchoan M, Rose MG. Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update. J Clin Oncol. 2024;42(15):1830\u201350.","journal-title":"J Clin Oncol"},{"issue":"11","key":"8634_CR31","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1002\/ajh.27443","volume":"99","author":"E Jabbour","year":"2024","unstructured":"Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring. Am J Hematol. 2024;99(11):2191\u2013212.","journal-title":"Am J Hematol"},{"key":"8634_CR32","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.lfs.2018.10.002","volume":"213","author":"I El Sayed","year":"2018","unstructured":"El Sayed I, Helmy MW, El-Abhar HS. Inhibition of SRC\/FAK cue: A novel pathway for the synergistic effect of rosuvastatin on the anti-cancer effect of dasatinib in hepatocellular carcinoma. Life Sci. 2018;213:248\u201357.","journal-title":"Life Sci"},{"issue":"9","key":"8634_CR33","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/ajh.26642","volume":"97","author":"E Jabbour","year":"2022","unstructured":"Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2022 update on diagnosis, therapy, and monitoring. Am J Hematol. 2022;97(9):1236\u201356.","journal-title":"Am J Hematol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08634-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08634-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08634-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T15:03:04Z","timestamp":1792162984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08634-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,18]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8634"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08634-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,18]]},"assertion":[{"value":"25 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethics Committee of Tongji Hospital of Tongji Medical College (Wuhan, China) and was conducted under the Guidelines of the Declaration of Helsinki. All patients provided full consent for the study. All animal experiments were conducted in accordance with the Guide for Care and Use of Laboratory Animals (National Research Council, USA), and the experimental protocols were reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of Tongji Hospital, Huazhong University of Science and Technology. All animals were euthanized in strict accordance with the Chinese national standard GB\/T 39760-2021 (Guidelines for the Humane Euthanasia of Laboratory Animals) and the American Veterinary Medical Association (AVMA) Guidelines for the Euthanasia of Animals (2020 edition).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1310"}}